Medtronic obtains CE Mark for vascular stent

| | Cardiovascular Business | Vascular & Endovascular

Medtronic has received CE Mark and initiated an international launch of its Complete SE (self-expanding) vascular stent for use in the lower extremities, specifically, the superficial femoral arteries (SFA) and proximal popliteal arteries.

The Complete SE stent has been approved by the FDA only for use in the iliac arteries. Its use in lower-extremity arteries in the U.S. is under review by the FDA, according to Minneapolis-based Medtronic. Previously CE Marked only for use in the iliac arteries, the Complete SE stent can now be used internationally in the lower extremities as well.

The new indication was obtained after clinical data from the Complete SE SFA study, an independently adjudicated single-arm, multicenter trial that enrolled 196 patients at 28 sites in the U.S. and Europe.

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."